Signatur Biosciences develops molecular diagnostic kits that condense complex RNA signatures into PCR assays, enabling faster and more accessible testing for diseases including breast cancer.
Signatur Biosciences develops molecular diagnostic kits that condense complex RNA signatures into PCR assays, enabling faster and more accessible testing for diseases including breast cancer.